Search hospitals > Michigan > Kalamazoo
Ascension Borgess Cancer Center
Claim this profileKalamazoo, Michigan 49009
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Oral Cancers
Conducts research for Lung Cancer
Conducts research for Gastroesophageal Junction Adenocarcinoma
81 reported clinical trials
1 medical researcher
Summary
Ascension Borgess Cancer Center is a medical facility located in Kalamazoo, Michigan. This center is recognized for care of Cancer, Breast Cancer, Oral Cancers, Lung Cancer, Gastroesophageal Junction Adenocarcinoma and other specialties. Ascension Borgess Cancer Center is involved with conducting 81 clinical trials across 271 conditions. There are 1 research doctors associated with this hospital, such as Kathleen J. Yost.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 positive
Stage II
Top PIs
Clinical Trials running at Ascension Borgess Cancer Center
Breast Cancer
Non-Small Cell Lung Cancer
Melanoma
Breast cancer
Lung Cancer
Bladder Cancer
Pancreatic Cancer
Cutaneous Melanoma
Gastric Cancer
Multiple Myeloma
Immunotherapy With or Without Surgery
for Kidney Cancer
This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, pembrolizumab, and avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Surgery to remove the kidney, called a nephrectomy, is also considered standard of care; however, doctors who treat kidney cancer do not agree on its benefits. It is not yet known if the addition of surgery to an immunotherapy-based drug combination works better than an immunotherapy-based drug combination alone in treating patients with kidney cancer.
Recruiting2 awards Phase 316 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Ascension Borgess Cancer Center?
Ascension Borgess Cancer Center is a medical facility located in Kalamazoo, Michigan. This center is recognized for care of Cancer, Breast Cancer, Oral Cancers, Lung Cancer, Gastroesophageal Junction Adenocarcinoma and other specialties. Ascension Borgess Cancer Center is involved with conducting 81 clinical trials across 271 conditions. There are 1 research doctors associated with this hospital, such as Kathleen J. Yost.